EG22658A - Matrix tablet enabling prolonged release of gliclazide after administration by the oral route - Google Patents

Matrix tablet enabling prolonged release of gliclazide after administration by the oral route

Info

Publication number
EG22658A
EG22658A EG20001261A EG20001261A EG22658A EG 22658 A EG22658 A EG 22658A EG 20001261 A EG20001261 A EG 20001261A EG 20001261 A EG20001261 A EG 20001261A EG 22658 A EG22658 A EG 22658A
Authority
EG
Egypt
Prior art keywords
gliclazide
administration
oral route
prolonged release
matrix tablet
Prior art date
Application number
EG20001261A
Inventor
De Bruno Huet Barochez
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Priority to EG20001261A priority Critical patent/EG22658A/en
Application granted granted Critical
Publication of EG22658A publication Critical patent/EG22658A/en

Links

EG20001261A 2000-10-04 2000-10-04 Matrix tablet enabling prolonged release of gliclazide after administration by the oral route EG22658A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EG20001261A EG22658A (en) 2000-10-04 2000-10-04 Matrix tablet enabling prolonged release of gliclazide after administration by the oral route

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EG20001261A EG22658A (en) 2000-10-04 2000-10-04 Matrix tablet enabling prolonged release of gliclazide after administration by the oral route

Publications (1)

Publication Number Publication Date
EG22658A true EG22658A (en) 2003-05-31

Family

ID=27589032

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20001261A EG22658A (en) 2000-10-04 2000-10-04 Matrix tablet enabling prolonged release of gliclazide after administration by the oral route

Country Status (1)

Country Link
EG (1) EG22658A (en)

Similar Documents

Publication Publication Date Title
HRP20010632A2 (en) Matrix tablet enabling prolonged release of gliclazide after administration by the oral route
IL155293A0 (en) Delayed release pharmaceutical formulations
AU6089200A (en) Rapid immediate release oral dosage form
EP1383376A4 (en) Pharmaceutical formulations for sustained release
CY2007031I2 (en) SUSTAINED RELEASE ORAL DOSAGE COMPOSITION
ZA200007715B (en) Stable extended release oral dosage composition.
HK1034455A1 (en) Oral pharmaceutical extended release dosage form.
CY2347B1 (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route.
EP1411904A4 (en) Sustained release pharmaceutical composition
MXPA03002569A (en) Controlled release formulations for oral administration.
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
EP1207852A4 (en) Controlled release oral dosage suitable for oral administration
PL376840A1 (en) Prolonged release pharmaceutical composition
EG22658A (en) Matrix tablet enabling prolonged release of gliclazide after administration by the oral route
EP1357898A4 (en) Improved controlled release oral dosage form
ZA200105511B (en) Oral solid pharmaceutical formulations with ph dependent multiphasic release
IL149853A0 (en) Gastroretentive controlled release pharmaceutical dosage forms